Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM159PT
TNBC
Basal B
Lestaurtinib
FLT3/JAK2/TrkA
RTK
11057.154
uM
0.93514
4.6160
-0.7352 -1.0000 0.6881 0.3694
0.9808
3.8498
SUM159PT
TNBC
Basal B
LBH589
HDAC
HDAC
11057.154
uM
0.24013
0.40952
-0.7352 -0.7529 1.7208 0.6122
0.9965
3.8498
SUM159PT
TNBC
Basal B
TCS 2312
CHK1
CHK
11057.152
uM
1.15310
1.13690
0.0039 0.0251 3.6451 0.2485
0.9981
3.8541
SUM159PT
TNBC
Basal B
NSC 663284
CDC25
CDC
11057.152
uM
2.59470
3.4840
-0.7348 -0.5153 2.4037 0.4415
0.9745
3.8541
SUM159PT
TNBC
Basal B
PD 98059
MEK
MAPK
11057.152
uM
172.25410
634.23160
0.7857 -0.9988 0.8422 0.0305
0.8640
3.8541
SUM159PT
TNBC
Basal B
Sigma A6730
AKT
AKT
11057.158
uM
11.04450
21.67290
-0.7343 -1.0000 1.6297 0.2053
0.9975
3.8594
SUM159PT
TNBC
Basal B
AS-252424
PI3K
PI3K
11057.158
uM
inf
3.06690
0.4735 0.5788 5.0000 0.0928
0.9104
3.8594
SUM159PT
TNBC
Basal B
Afatinib
EGFR/HER2
ErbB
11057.158
uM
3.9340
7.18480
-0.7343 -0.7885 1.5717 0.3293
0.9976
3.8594
SUM159PT
TNBC
Basal B
TCS PIM-1 1
Pim kinase
PIM
11057.135
uM
inf
30.93790
0.6673 0.6670 4.9977 0.0270
0.9663
3.9340
SUM159PT
TNBC
Basal B
Pevonedistat
NAE1
NAE1
11057.135
uM
1.28990
0.96672
0.1560 0.1358 1.0990 0.2860
0.9973
3.9340
SUM159PT
TNBC
Basal B
Olomoucine II
CDK1
CDK
11057.147
uM
7.28880
6.97660
0.0532 0.0438 2.0939 0.2366
0.9949
3.9818
SUM159PT
TNBC
Basal B
NU6102
CDK1/2
CDK
11057.147
uM
17.1090
24.21920
-0.1545 -0.3781 1.6205 0.1481
0.9919
3.9818
SUM159PT
TNBC
Basal B
Oxamflatin
HDAC
HDAC
11057.147
uM
0.84250
4.57980
-0.7232 -1.0000 0.6489 0.4577
0.9988
3.9818
SUM159PT
TNBC
Basal B
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
11057.15
uM
2.65110
41.24140
0.0213 -0.9986 0.4000 0.2444
0.9757
4.0042
SUM159PT
TNBC
Basal B
ZM-447439
AURK
AURK
11057.15
uM
inf
0.43340
0.6315 0.6227 5.0000 0.1138
0.9875
4.0042
SUM159PT
TNBC
Basal B
Glycyl-H-1152
ROCK2
11057.15
uM
inf
1.87160
0.6613 0.6691 2.5283 0.0649
0.9799
4.0042
SUM159PT
TNBC
Basal B
Baicalein
Lipoxygenase
Metabolism
11057.072
uM
240.88130
167.67830
0.6604 0.3171 2.7765 0.0050
0.9563
4.0230
SUM159PT
TNBC
Basal B
Sulindac sulfide
COX1/2
COX
10520.136
uM
inf
inf
0.9767 0.9767 0.0000 -0.0015
0.0597
4.0331
SUM159PT
TNBC
Basal B
Celecoxib
COX2
COX
10520.136
uM
inf
inf
0.9370 0.9370 0.0000 0.0170
0.1158
4.0331
SUM159PT
TNBC
Basal B
PD 98059
MEK
MAPK
10520.136
uM
inf
60.9410
0.7037 0.5045 0.8153 0.0356
0.8909
4.0331
SUM159PT
TNBC
Basal B
FR180204
ERK1/2
MAPK
11057.149
uM
138.43220
340.81150
0.7733 -0.4654 0.7303 0.0467
0.7551
4.1019
SUM159PT
TNBC
Basal B
L-779450
BRAF
MAPK
11057.149
uM
29.35970
49.41790
0.4099 -0.8250 1.8716 0.0368
0.9824
4.1019
SUM159PT
TNBC
Basal B
5-DFUR
TYMS
TYMS
11057.143
uM
117.49380
138.80550
0.0197 -0.0551 0.6266 0.3060
0.9924
4.1426
SUM159PT
TNBC
Basal B
Ibandronate
FDPS
11057.143
uM
98.76930
55.29940
0.2436 0.2680 1.3241 0.1795
0.9859
4.1426
SUM159PT
TNBC
Basal B
Valproic acid
HDAC
HDAC
11057.143
uM
761.54820
1000.00000
-0.5710 -0.1965 1.2168 0.2071
0.8155
4.1426